Session IV. Implications from Clinical Finding of GI Cancers (Oral presentation)
|
1 |
CA19-9 Is an Independent Prognostic factor for Locally Advanced Pancreatic Cancer Patients Treated with Chemoradiotherapy |
Á¤¹®Àç(¿¬¼¼ÀÇ´ë) |
|
2 |
FOLFOX4 as a Rescue Chemotherapy in Gemcitabine Based Chemotherapy Refractory Pancreatic Cancer |
ÀåÈñ¿ø(¿¬¼¼ÀÇ´ë) |
|
3 |
¼ö¼úÀû ÀýÁ¦°¡ ºÒ°¡´ÉÇÑ ÃéÀå¾Ï¿¡ ´ëÇÑ Ç׾Ͽä¹ý ½ÃÇà ÈÄ 2³â ÀÌ»ó »ýÁ¸ÇÑ È¯Àڵ鿡 ´ëÇÑ ÀÓ»óÀû °íÂû |
¾Èµ¿¿ø(¼¿ïÀÇ´ë) |
|
4 |
Clinical Usefulness of CD44 as a Chemotherapeutic Marker in Pancreatobiliary Cancer |
¹Ú¼¼¹Ì(¿¬¼¼ÀÇ´ë) |